OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Perspectives in Cancer Immunotherapy
Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 185
Theodoulakis Christofi, Stavroula Baritaki, Luca Falzone, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 185
Showing 1-25 of 185 citing articles:
Targeting STAT3 in Cancer Immunotherapy
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 704
Sailan Zou, Qiyu Tong, Bowen Liu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 704
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
Aristides Tsatsakis, Daniela Călina, Luca Falzone, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111769-111769
Open Access | Times Cited: 151
Aristides Tsatsakis, Daniela Călina, Luca Falzone, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111769-111769
Open Access | Times Cited: 151
Identification of tumor antigens with immunopeptidomics
Chloé Chong, George Coukos, Michal Bassani‐Sternberg
Nature Biotechnology (2021) Vol. 40, Iss. 2, pp. 175-188
Closed Access | Times Cited: 146
Chloé Chong, George Coukos, Michal Bassani‐Sternberg
Nature Biotechnology (2021) Vol. 40, Iss. 2, pp. 175-188
Closed Access | Times Cited: 146
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y. Chiang, Ira Mellman
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004711-e004711
Open Access | Times Cited: 122
Eugene Y. Chiang, Ira Mellman
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004711-e004711
Open Access | Times Cited: 122
Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma
Salvatore Napoli, Chiara Scuderi, Giuseppe Gattuso, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1151-1151
Open Access | Times Cited: 109
Salvatore Napoli, Chiara Scuderi, Giuseppe Gattuso, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1151-1151
Open Access | Times Cited: 109
Cutaneous melanoma and the immunotherapy revolution (Review)
Giulia C. Leonardi, Saverio Candido, Luca Falzone, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 3, pp. 609-618
Open Access | Times Cited: 94
Giulia C. Leonardi, Saverio Candido, Luca Falzone, et al.
International Journal of Oncology (2020) Vol. 57, Iss. 3, pp. 609-618
Open Access | Times Cited: 94
Association of oral dysbiosis with oral cancer development (Review)
Giusy Rita Maria La Rosa, Giuseppe Gattuso, Eugenio Pedull�, et al.
Oncology Letters (2020)
Open Access | Times Cited: 91
Giusy Rita Maria La Rosa, Giuseppe Gattuso, Eugenio Pedull�, et al.
Oncology Letters (2020)
Open Access | Times Cited: 91
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review)
Luca Falzone, Giuseppa Scandurra, Valentina Lombardo, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 1
Open Access | Times Cited: 88
Luca Falzone, Giuseppa Scandurra, Valentina Lombardo, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 1
Open Access | Times Cited: 88
Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment
Ka Hong Wong, Aiping Lü, Xiaoyu Chen, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3620-3620
Open Access | Times Cited: 85
Ka Hong Wong, Aiping Lü, Xiaoyu Chen, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3620-3620
Open Access | Times Cited: 85
Patient-Derived Organoids for Precision Cancer Immunotherapy
Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, et al.
Cancer Research (2021) Vol. 81, Iss. 12, pp. 3149-3155
Open Access | Times Cited: 84
Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, et al.
Cancer Research (2021) Vol. 81, Iss. 12, pp. 3149-3155
Open Access | Times Cited: 84
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
Silvia Vivarelli, Luca Falzone, Caterina Grillo, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2237-2237
Open Access | Times Cited: 78
Silvia Vivarelli, Luca Falzone, Caterina Grillo, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2237-2237
Open Access | Times Cited: 78
Druggable genome and precision medicine in cancer: current challenges
Camille Dupont, Kristina Riegel, Malvika Pompaiah, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6142-6158
Open Access | Times Cited: 69
Camille Dupont, Kristina Riegel, Malvika Pompaiah, et al.
FEBS Journal (2021) Vol. 288, Iss. 21, pp. 6142-6158
Open Access | Times Cited: 69
Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies
Wendi Kang, Zhichao Feng, Jianwei Luo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Wendi Kang, Zhichao Feng, Jianwei Luo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Targeting interleukin-1β and inflammation in lung cancer
Jun Zhang, Nirmal K. Veeramachaneni
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 58
Jun Zhang, Nirmal K. Veeramachaneni
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 58
Gold Nanoparticles Based Optical Biosensors for Cancer Biomarker Proteins: A Review of the Current Practices
Jinghua Tai, Shuang Fan, Siqi Ding, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 51
Jinghua Tai, Shuang Fan, Siqi Ding, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 51
Melanoma therapeutics: a literature review
Pavan Kumar Dhanyamraju, Trupti Patel
Journal of Biomedical Research (2022) Vol. 36, Iss. 2, pp. 77-77
Open Access | Times Cited: 40
Pavan Kumar Dhanyamraju, Trupti Patel
Journal of Biomedical Research (2022) Vol. 36, Iss. 2, pp. 77-77
Open Access | Times Cited: 40
Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach
Mahshad Entezam, Mohammad‐Javad Sanaei, Yousef Mirzaei, et al.
Life Sciences (2023) Vol. 318, pp. 121459-121459
Closed Access | Times Cited: 26
Mahshad Entezam, Mohammad‐Javad Sanaei, Yousef Mirzaei, et al.
Life Sciences (2023) Vol. 318, pp. 121459-121459
Closed Access | Times Cited: 26
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 10
Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2158-2158
Open Access | Times Cited: 10
A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155
Bushra Husain, Sree R. Ramani, Eugene Y. Chiang, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 11, pp. 2310-2323
Open Access | Times Cited: 70
Bushra Husain, Sree R. Ramani, Eugene Y. Chiang, et al.
Molecular & Cellular Proteomics (2019) Vol. 18, Iss. 11, pp. 2310-2323
Open Access | Times Cited: 70
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Alexey V. Baldin, Lyudmila V. Savvateeva, Alexandr V. Bazhin, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 590-590
Open Access | Times Cited: 69
Alexey V. Baldin, Lyudmila V. Savvateeva, Alexandr V. Bazhin, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 590-590
Open Access | Times Cited: 69
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
Niloy R. Datta, H. Petra Kok, Johannes Crezee, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63
Niloy R. Datta, H. Petra Kok, Johannes Crezee, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 63
High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer
Mara Kitsou, Georgios Ayiomamitis, Apostolos Zaravinos
International Journal of Oncology (2020) Vol. 57, Iss. 1, pp. 237-248
Open Access | Times Cited: 60
Mara Kitsou, Georgios Ayiomamitis, Apostolos Zaravinos
International Journal of Oncology (2020) Vol. 57, Iss. 1, pp. 237-248
Open Access | Times Cited: 60
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
Jerri C. Caldeira, Michael Perrine, Federica Pericle, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 488-488
Open Access | Times Cited: 58
Jerri C. Caldeira, Michael Perrine, Federica Pericle, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 488-488
Open Access | Times Cited: 58
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review)
Silvia Vivarelli, Luca Falzone, Francesco Torino, et al.
International Journal of Oncology (2020) Vol. 58, Iss. 2, pp. 145-157
Open Access | Times Cited: 58
Silvia Vivarelli, Luca Falzone, Francesco Torino, et al.
International Journal of Oncology (2020) Vol. 58, Iss. 2, pp. 145-157
Open Access | Times Cited: 58
